Phibro Animal Health | PAHC - Des Atouts





Des Atouts Changement Date
Align Technology USD 6.23B 141K 2025-12
ANI Pharmaceuticals USD 1.44B 32.22M 2025-12
Assertio Holdings USD 319.77M 46M 2025-09
Aurora Cannabis CAD 775.29M 18.43M 2025-12
Bristol-Myers Squibb USD 96.89B 2.21B 2025-09
Canopy Growth CAD 1.11B 36.35M 2025-12
Corcept Therapeutics USD 836.65M 13.04M 2025-12
Eli Lilly USD 112.48B 2.46B 2025-12
Henry Schein USD 11.22B 118M 2025-12
Idexx Laboratories USD 3.35B 35.95M 2025-12
Knight Therapeutics CAD 1.05B 2.28M 2025-12
Merck USD 129.55B 12.02B 2025-09
Nektar Therapeutics USD 301.35M 93.81M 2025-09
Pacira USD 1.26B 32.66M 2025-12
Phibro Animal Health USD 1.41B 20.03M 2025-12
Prestige Brands USD 3.49B 52.46M 2025-12
Supernus Pharmaceuticals USD 1.45B 32.89M 2025-12
Zoetis USD 15.47B 308M 2025-12